Ownership of this website has been transferred from Northwestern University to Michigan State University. Please note that some site information may be inaccurate while adjustments to reflect this organizational change are made.
Dr. Monique Hinchcliff is the Associate Clinical Director and the Director of Translational Research for the Northwestern Scleroderma Program. Her research interests include the use of high-throughput, unbiased, approaches to define clinically relevant molecular subsets of systemic sclerosis/...
Today's speaker bio is Kyle Orwig, PhD, from the University of Pittsburgh. Dr. Orwig will be giving a talk at the conference entitled: Stem Cell Therapies for Male Infertility.
Dr. Orwig joined the faculty of the University of Pittsburgh in 2003 and is currently Associate Professor of Obstetrics,...
In anticipation of the Oncofertility Consortium Conference on September 22-23, we will be showcasing our conference speakers in an upcoming series of blogs. Each year the OC conference features the leading national and international experts in the field of fertility preservation. This year's...
A recent feature in Cure magazine discusses adoption as another option for cancer survivors who want to build a family. Each patient is unique. The impact of a given treatment on fertility can vary and so can the time available before starting life saving treatments. Patient age, marital status,...
Gonadotoxic therapies, such as chemotherapy, used to treat breast cancer can have harmful effects on fertility- they destroy ovarian follicles, or women's reserve of ova, resulting in amenorrhea and/or early menopause. Additionally, many endocrine therapies used to treat breast cancer have indirect...
A variety of patient education materials have been created for providers to use in the oncofertility care setting- materials that describe fertility preservation options in easy-to-understand language and have been designed in multiple platforms ranging from informational fact sheets to internet...
Need to stay up to date on the latest clinical guidelines, recommendations, and opinions? Our Oncofertility Decision Tool Web Portal has an entire section devoted to bringing you ALL of the clinical guidelines affecting fertility preservation and oncology care. We designed it this way so the...
Yesterday we announced our NEW Oncofertility Decision Tool Web Portal. This online portal serves as a one-stop-shop for health care providers in need of tools to facilitate fertility preservation conversations with their patients whose disease, or its treatment, threatens fertility. In addition to...
The Oncofertility Consortium has created a Decision Tool Web Portal for health care providers who care for patients diagnosed with malignant and non-malignant conditions which may impair fertility (or treatment may impair fertility).
Decision Tools are designed to enable oncofertility stakeholders...
Today, we are honored to have another patient guest blogger; long-term survivor Colleen Cira. Read through her incredible story below and join the Robert H. Lurie Comprehensive Cancer Center this evening, March 25, from 5-8pm for "Drinks with Docs (& Healthcare Providers)" at Bridge House Tavern...
Today we welcome Dr. So-Youn Kim from Dr. Woodruff's Lab at Northwestern University as our guest blogger. Dr. Kim will review a recent article published by Dr. John C. Schimenti in Science 2014. ONE MORE STEP TOWARDS PRESERVING OOCYTE RESERVE
By: So-Youn Kim, PhD
According to a paper published by...
The Oncofertility Consortium is happy to welcome the Portuguese Center for Fertility Preservation as a Global Partner. We currently work with reproductive specialists from all over the world in an effort to better serve children, adolescents and young adults with cancer and other fertility-...
The contents of the Oncofertility Consortium Blog are for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.